BMC News

Release: New Study Reveals BC Government’s Healthcare Silo Approach to Drug Policy Cost $43.5 million

The Canadian Society of Intestinal Research, a BMC member, has published a study revealing the high costs resulting from British Columbia's therapeutic substition policy (Released January 22, 2009)

Article: New agency to probe drug safety

Article in The Toronto Star about Health Canada's newly announced drug safety network for the post-market surveillance of medications (Published January 15, 2009)

Letter to the Editor: The dismal state of drug access in this country

Letter to the Editor on the dismal state of drug access in Canada and the need for a made-in-Canada approach to meet this challenge (Published December 3, 2008)

Release: Patients applaud broadened access to key treatments in Ontario

Media Release supporting an announcement by the Ontario Public Drug Program to reimburse six new treatments effective today (Released December 3, 2008)

Letter to the Editor: Treatments in U.S. aren't always easy

Letter to the Editor arguing that simply spending money on healthcare does not guarantee good healthcare (Published Tuesday, October 7, 2008)

Take Action

Take Action!

BMC encourages individuals and members to speak out to decision-makers on treatment access issues.

 

Click here to find out more

question_mark.gif

Did You Know?

Currently, only 1-10% of drug-related adverse events are reported to Canadian authorities. Find Out More